NCT07021989
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07021989
Title ctDNA-Guided Therapy for Relapsed/Refractory Hodgkin Lymphoma
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Michael Spinner, MD
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of California Davis Davis California 95616 United States Details
University of California San Francisco-Fresno Fresno California 93701 United States Details
University of California Irvine Irvine California 92617 United States Details
University of California, San Diego La Jolla California 92093 United States Details
Unversity of California, Los Angeles Los Angeles California 90095 United States Details
University of California, San Francisco San Francisco California 94143 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field